Eastman Chemical (NYSE: EMN) reported Q2 EPS of $0.85, $0.20 worse than the analyst estimate of $1.05. Revenue for the quarter came in at $1.92 billion versus the consensus estimate of $1.83 billion.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.